These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 9402106)

  • 1. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro.
    Lindner DJ; Borden EC
    J Interferon Cytokine Res; 1997 Nov; 17(11):681-93. PubMed ID: 9402106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Lindner DJ; Borden EC; Kalvakolanu DV
    Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis.
    Lindner DJ; Borden EC
    Int J Cancer; 1997 May; 71(3):456-61. PubMed ID: 9139884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human recombinant interferon-beta SER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse.
    Gibson DF; Johnson DA; Goldstein D; Langan-Fahey SM; Borden EC; Jordan VC
    Breast Cancer Res Treat; 1993; 25(2):141-50. PubMed ID: 8347846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen enhances interferon-regulated gene expression in breast cancer cells.
    Lindner DJ; Kolla V; Kalvakolanu DV; Borden EC
    Mol Cell Biochem; 1997 Feb; 167(1-2):169-77. PubMed ID: 9059994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.
    Jordan VC; Gottardis MM; Robinson SP; Friedl A
    J Steroid Biochem; 1989; 34(1-6):169-76. PubMed ID: 2626014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen.
    Abe-Hashimoto J; Kikuchi T; Matsumoto T; Nishii Y; Ogata E; Ikeda K
    Cancer Res; 1993 Jun; 53(11):2534-7. PubMed ID: 8495416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay.
    Higashihara J; Saito T; Berens ME; Welander CE
    Cancer Chemother Pharmacol; 1988; 22(3):215-22. PubMed ID: 3136942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR; Sutherland RL
    Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
    Bruzzese F; Di Gennaro E; Avallone A; Pepe S; Arra C; Caraglia M; Tagliaferri P; Budillon A
    Clin Cancer Res; 2006 Jan; 12(2):617-25. PubMed ID: 16428508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human interferon-alpha 2a increases hormone receptor level of a human breast carcinoma xenograft in nude mice and enhances the anti-proliferative activity of tamoxifen.
    Josui K; Kubota T; Kitajima M
    Jpn J Cancer Res; 1992 Dec; 83(12):1347-53. PubMed ID: 1483948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
    Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
    Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR; Murphy LC; Hall RE; Sutherland RL
    Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer.
    Tantivejkul K; Vucenik I; Eiseman J; Shamsuddin AM
    Breast Cancer Res Treat; 2003 Jun; 79(3):301-12. PubMed ID: 12846414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
    Toi M; Bicknell R; Harris AL
    Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of type I and II interferons on cultured human breast cells: interaction with estrogen receptors and with tamoxifen.
    Goldstein D; Bushmeyer SM; Witt PL; Jordan VC; Borden EC
    Cancer Res; 1989 May; 49(10):2698-702. PubMed ID: 2469536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: in vitro and in vivo evaluation.
    Jain AS; Goel PN; Shah SM; Dhawan VV; Nikam Y; Gude RP; Nagarsenker MS
    Biomed Pharmacother; 2014 May; 68(4):429-38. PubMed ID: 24721327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of interferon beta on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin.
    Bauer JA; Morrison BH; Grane RW; Jacobs BS; Dabney S; Gamero AM; Carnevale KA; Smith DJ; Drazba J; Seetharam B; Lindner DJ
    J Natl Cancer Inst; 2002 Jul; 94(13):1010-9. PubMed ID: 12096086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.